Skip to main content
. 2013 Jun 28;8:797–807. doi: 10.2147/CIA.S43817

Table 1.

Quality of systematic review (AMSTAR quality indicators)

Article Primary goal included studies Quality of systematic review (AMSTAR quality indicators)
Was a priori design provided? Was there duplicate study selection and data extraction? Was a comprehensive literature search performed? Was the status of publication (ie, grey literature) used as an inclusion criterion? Was a list of studies (included and excluded) provided? Were the characteristics of the included studies provided? Was the scientific quality of the included studies assessed and documented? Was the scientific quality of the included studies used appropriately in formulating conclusions? Were the methods used to combine the findings of studies appropriate? Was the likelihood of publication bias assessed? Was the conflict of interest included?
AMSTAR
Winkelmayer22 To evaluate the cost-effectiveness of renal replacement therapy 13 observational and economic modeling studies Yes Not mentioned No, search restricted to English Yes Yes included No excluded Yes No Yes Yes No No
Mowatt24 To assess the effectiveness and cost effectiveness of home HD compared with HD carried out in a hospital or satellite unit 27 reviews, comparative observational studies and randomized crossover trial Yes Yes Non-English studies identified but not evaluated No Yes Yes Yes Yes Yes No Funding source listed no conflict of interest statement
Murtagh14 To identify the prevalence of symptoms in patients with ESRD on HD, non-dialytic management and discontinuing dialysis 60 prospective and retrospective cross sectional data one of which collected longitudinal data Yes Study selection No data extraction Yes on a random sample No, search restricted to English No Yes included No excluded Yes Yes Yes Yes No No
Lazarides21 To compare outcomes of various angioaccess procedures in elderly patients 13 cohort observational studies Yes No No, search restricted to English No Yes Yes No Yes Yes Yes No
Schmitt19 To determine the incidence of non-recovery of kidney function after acute kidney injury 17 retrospective cohort and randomized controlled trials Yes Yes No, search restricted to English Yes Yes included No excluded Yes Yes Yes Yes No Yes
Morton9 To synthesize and analyze the views of patients and caregivers on decision making and choice for treatments in patients with chronic kidney disease 18 qualitative studies Yes Yes No, search restricted to English No Yes included No excluded Yes Yes Yes Yes No Yes
Johnson20 To formulate and express a prognostic assessment for a patient with acute renal failure requiring RRT in the Intensive care unit 41 cohort, and RCT studies Yes No No, search restricted to English Yes Yes included No excluded Yes but just number of patients, setting and outcomes, not study type No No Yes No Yes
Menzin23 To identify interventions in chronic kidney disease that provide reasonable value and potential to lower cost and improve quality 84 observational and economic modeling studies Yes Yes No, search restricted to English Yes No Some, description, time horizon perspective but not study type No Yes Yes No Yes
O’Connor18 To summarize evidence on non-dialytic management of ESRD regarding prognosis and QoL 13 cohort, cross sectional and observational studies Yes Yes Yes No Yes included No excluded Yes Yes Yes N/A No Yes

Notes: Ninety-two citations identified in Ovid Medline In-Process and Other Non-Indexed Citations, Ovid MEDLINE, Ovid EMBASE, Ovid Cochrane Database of Systematic Reviews, and Scopus. Eighty-three citations excluded by review of title and abstract. Nine articles reviewed. Five articles excluded based on inclusion and exclusion criteria. Two nonsystematic reviews. Two reviews comparing specific dialysis techniques. One review assessing reasons for late referral. Four articles selected. Two additional articles identified through review of references. Three additional articles identified through expert colleagues. Nine articles included in final review.

Abbreviations: AMSTAR, a measurement tool to assess systematic reviews; ESRD, end-stage renal disease; HD, hemodialysis; QoL, quality of life; RRT, renal replacement therapy; RCT, randomized controlled trial.